Clinical Updates
Drug approvals, guideline changes, and treatment advances
Biotech M&A Accelerates: AbbVie’s Apogee Deal Signals Return of Major Acquisitions
AbbVie's acquisition of Apogee Therapeutics marks a significant return to biotech M&A activity after an extended sector slowdown. Recent positive…
Editor's Top Picks
Candida auris endocarditis emerges as life-threatening infection in hospitalised patients
A rare but serious heart infection caused by the multidrug-resistant fungus Candida auris is emerging in hospitalised patients, presenting major…
Submit Your Paper →
More form Clinical Updates
Wegovy Shows Higher Risk of Rare Eye Stroke Causing Sudden Vision Loss
New FDA database analysis reveals Wegovy carries 5x higher risk of rare eye stroke compared…
Zinc-Copper Imbalance: How High-Dose Zinc Supplements Create Hidden Deficiencies
High-dose zinc supplements can cause copper deficiency within weeks due to competitive absorption. Research shows…
Spinal Nerve Network Controls Body Functions Beyond Back Pain, Research Shows
New research reveals the spine functions as the body's central wiring harness, with each vertebral…
Biogen-Denali Parkinson’s Drug Fails Phase 2 Trial, Highlighting Treatment Development Challenges
Biogen and Denali's experimental Parkinson's therapy failed Phase 2 trial endpoints, highlighting ongoing challenges in…
EU and US Drug Regulators Split Over AstraZeneca’s New Breast Cancer Treatment
European and American drug regulators reached opposing conclusions on AstraZeneca's experimental breast cancer treatment. The…